Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 2, 2006, Pages 291-296

  Skrabal, Christian A ^a   Choi, Yeong H ^a   Kaminski, Alexander ^a   Steiner, Michael ^a   Kundt, Guenther ^a   Steinhoff, Gustav ^a   Liebold, Andreas ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CELL COUNT; CIRCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE MARKER; ENDOTHELIUM CELL; ENDOTHELIUM LESION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; FEMALE; HEART MUSCLE; HUMAN; IMMUNOMAGNETIC SEPARATION; MALE; OBSERVATION; PERIOPERATIVE PERIOD; PLASMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TIME; VOLUNTEER;

AGED; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASES; CELL COUNT; CELL SEPARATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; THROMBOMODULIN; VON WILLEBRAND FACTOR;

EID: 33746209060     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.03.017     Document Type: Article

References (29)

1. Grover F.L. The Society of Thoracic Surgeons National Database. current status and future directions. Ann Thorac Surg 68 (1999) 367-373 discussion 374-6
2. Kirklin J.K., Westaby S., Blackstone E.H., Kirklin J.W., Chenoweth D.E., and Pacifico A.D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86 (1983) 845-857
3. Ascione R., Lloyd C.T., Underwood M.J., Lotto A.A., Pitsis A.A., and Angelini G.D. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69 (2000) 1198-1204
4. Asimakopoulos G. Mechanisms of the systemic inflammatory response. Perfusion 14 (1999) 269-277
5. Fromes Y., Gaillard D., Ponzio O., Chauffert M., Gerhardt M.F., Deleuze P., et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 22 (2002) 527-533
6. Wiesenack C., Liebold A., Philipp A., Ritzka M., Koppenberg J., Birnbaum D.E., et al. Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs 28 (2004) 1082-1088
7. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation. pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 (2002) 232-244
8. McClung J.A., Naseer N., Saleem M., Rossi G.P., Weiss M.B., Abraham N.G., et al. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia 48 (2005) 345-350
9. Haubitz M., and Woywodt A. Circulating endothelial cells and vasculitis. Intern Med 43 (2004) 660-667
10. Dignat-George F., and Sampol J. Circulating endothelial cells in vascular disorders. new insights into an old concept. Eur J Haematol 65 (2000) 215-220
11. Mutin M., Canavy I., Blann A., Bory M., Sampol J., and Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 93 (1999) 2951-2958
12. Wierzbowska A., Robak T., Krawczynska A., Wrzesien-Kus A., Pluta A., Cebula B., et al. Circulating endothelial cells in patients with acute myeloid leukaemia. Eur J Haematol 75 (2005) 492-497
13. Woywodt A., Schroeder M., Gwinner W., Mengel M., Jaeger M., Schwarz A., et al. Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation 76 (2003) 1-4
14. Woywodt A., Goldberg C., Scheer J., Regelsberger H., Haller H., and Haubitz M. An improved assay for enumeration of circulating endothelial cells. Ann Hematol 83 (2004) 491-494
15. Woywodt A., Streiber F., de Groot K., Regelsberger H., Haller H., and Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 361 (2003) 206-210
16. Solovey A., Lin Y., Browne P., Choong S., Wayner E., and Hebbel R.P. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337 (1997) 1584-1590
17. Woywodt A., Bahlmann F.H., De Groot K., Haller H., and Haubitz M. Circulating endothelial cells. life, death, detachment and repair of the endothelial cell layer. Nephrol Dial Transplant 17 (2002) 1728-1730
18. Chong A.Y., Blann A.D., Patel J., Freestone B., Hughes E., and Lip G.Y. Endothelial dysfunction and damage in congestive heart failure. relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation 110 (2004) 1794-1798
19. Scholz M., Nowak P., Blaheta R., Schuller A., Menon S., Cinatl J., et al. Relocalization of endothelial cell beta-catenin after coculture with activated neutrophils from patients undergoing cardiac surgery with cardiopulmonary bypass. J Invest Surg 17 (2004) 143-149
20. Bardin N., George F., Mutin M., Brisson C., Horschowski N., Frances V., et al. S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 48 (1996) 531-539
21. Salomaa V., Matei C., Aleksic N., Sansores-Garcia L., Folsom A.R., Juneja H., et al. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study. a case-cohort study. Lancet 353 (1999) 1729-1734
22. Conway D.S., Pearce L.A., Chin B.S., Hart R.G., and Lip G.Y. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation 107 (2003) 3141-3145
23. Gong J., Larsson R., Ekdahl K.N., Mollnes T.E., Nilsson U., and Nilsson B. Tubing loops as a model for cardiopulmonary bypass circuits. both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model. J Clin Immunol 16 (1996) 222-229
24. Gourlay T., Samartzis I., and Taylor K.M. The effect of haemodilution on blood-biomaterial contact-mediated CD11b expression on neutrophils. ex vivo studies. Perfusion 18 (2003) 87-93
25. Aldea G.S., Soltow L.O., Chandler W.L., Triggs C.M., Vocelka C.R., Crockett G.I., et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 123 (2002) 742-755
26. Westerberg M., Bengtsson A., and Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg 78 (2004) 54-59
27. Andersen K.S., Nygreen E.L., Grong K., Leirvaag B., and Holmsen H. Comparison of the centrifugal and roller pump in elective coronary artery bypass surgery-a prospective, randomized study with special emphasis upon platelet activation. Scand Cardiovasc J 37 (2003) 356-362
28. Linneweber J., Chow T.W., Kawamura M., Moake J.L., and Nose Y. In vitro comparison of blood pump induced platelet microaggregates between a centrifugal and roller pump during cardiopulmonary bypass. Int J Artif Organs 25 (2002) 549-555
29. Parolari A., Alamanni F., Naliato M., Spirito R., Franze V., Pompilio G., et al. Adult cardiac surgery outcomes. role of the pump type. Eur J Cardiothorac Surg 18 (2000) 575-582